International Companies
Proof of Covid-19 vaccination may be required for travel, says Qantas
International passengers will only be able to travel on Qantas flights if they have been vaccinated against Covid-19, the airline’s chief executive has suggested.
Airbnb finally files for end-2020 IPO
Airbnb finally filed for its long-awaited initial public offering on Monday and is reportedly aiming to raise $3bn in a transaction that would give it a valuation of $30bn.
Merck to buy Oncolmmune for $425m
Merck has agreed to buy privately-held, clinical-stage biopharmaceutical company OncoImmune for an upfront payment of $425m in cash.
CMA mulling opening investigation into Google 'privacy sandbox' adtech
The UK’s Competitive Markets Authority is mulling whether to open an investigation into Google after receiving a complaint against what a group of companies alleged was an anticompetitive new advertising technology which the search giant was set to roll-out early in 2020.
Danone to cut 2,000 jobs as part of company-wide overhaul
Danone is to cut up to 2,000 jobs, or 2% of its global workforce, as part of a wide-reaching overhaul of the business intended to save more than €1bn by 2023.
Aviva sells Italian life joint venture stake for €400m
Aviva has agreed to sell its 80% stake in its Italian life insurance joint venture to its partner UBI Banca for €400m (£356m) in cash as the insurer continues to reduce its international operations.
FDA grants EUA for Eli Lilly treatment in conjunction with Remdesivir
The Food and Drug Administration has granted Emergency Use Approval for baricitinib, a treatment for Covid-19 developed jointly by Eli Lilly and Incyte, in combination with Gilead Sciences's remdesivir.
WHO advises against prescribing remdesivir for Covid-19
WHO advises doctors against treating Covid-19 patients with Gilead Science’s remdesivir drug (under the name Veklury) that has “no meaningful effect” on survival or need for ventilation.
Pfizer and BioNTech file for emergency use approval of Covid-19 vaccine with FDA
Pfizer and BioNTech have filed for Emergency Use Authorisation with America's drug regulator for their Covid-19 vaccine candidate, BNT162b2.
Telit considers u-blox takeover approach
Telit Communications said it had received an all-share bid approach from Swiss rival u-blox valuing and was considering the proposal.
Macy's quarterly sales slump amid ongoing Covid-19 pandemic
Retailer Macy's revealed on Thursday that quarterly sales had slumped more than a fifth as consumers dialled back spending throughout the Covid-19 pandemic.
CMA to probe Virgin-O2 merger
The Competition and Markets Authority will carry out a full investigation of the merger between Virgin Media and O2 after the European commission referred the deal to the UK.
Thyssenkrupp swings to FY loss, announces more job cuts
German steel firm Thyssenkrupp swung to a loss on Thursday, leading the group to cut jobs amid increased pressure on the company as a result of the Covid-19 pandemic.
Target beats Q3 earnings expectations
US retailer Target easily surpassed earnings expectations with its third-quarter results on Wednesday, buoyed by an improved online sales performance.
Pfizer Covid-19 vaccine more than 94% effective in older adults
The Covid-19 vaccine candidate being developed by Pfizer and BioNTech has shown an elevated degree of efficacy in preventing Covid-19 among those aged 65 and over.
US to approve Boeing 737 MAX return after exhaustive reviews
The US Federal Aviation Administration is set to approve the return of the Boeing 737 MAX to the skies after two years of scrutiny and a standoff with global regulators.
Pfizer Covid-19 vaccine meets safety milestone, will submit for EUA
Pfizer has reached a key safety milestone for its Covid-19 vaccine candidate, having collected two months' worth of follow-on safety data from the volunteers dosed in its late stage clinical trial.
Unilever sets goal for €1bn annual sales of plant-based items
Unilver has set itself the target of reaching annual sales of plant-based foodstuffs worth €1bn.
Pfizer to start pilot delivery program for Covid-19 vaccine
Pharmaceutical company Pfizer will begin trials in four US states for the delivery program for the Covid-19 vaccine that it is developing.
WHO warns 'no time for complacency' despite Covid-19 vaccine
The World Health Organization (WHO) said that although the announcements of new potential effective vaccines for Covid-19 are positive news, “many questions” remain and there is no time for complacency.